SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, hinders the PI3K/Akt pathway, crucial in various cellular processes. This inhibition may indirectly suppress Vmn1r209 by disrupting signaling pathways that regulate its expression in sensory neurons. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor, known to affect inflammatory responses. Inhibiting p38 MAP kinase could reduce Vmn1r209 expression by attenuating signaling pathways involved in inflammation, potentially influencing its role in sensory perception. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126, a MEK inhibitor, targets the ERK pathway. This inhibition may lead to a decrease in Vmn1r209 expression if the gene is involved in cellular responses mediated by the ERK pathway, particularly in sensory neurons. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, a potent PI3K inhibitor, can disrupt various signaling pathways, including those related to sensory perception. This broad inhibition could lead to decreased Vmn1r209 expression if it is regulated by PI3K-dependent pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, a MEK inhibitor, disrupts the MAPK/ERK pathway. This action can potentially downregulate Vmn1r209 expression by interfering with pathways involved in sensory processing. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, affects cell growth and proliferation. Inhibiting mTOR could lead to decreased Vmn1r209 expression, especially if the gene is involved in pathways related to cell growth and sensory neuron function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1, an inhibitor of vacuolar-type H+-ATPase, can disrupt lysosomal acidification. This might reduce Vmn1r209 expression if the gene is involved in processes influenced by lysosomal function, possibly in sensory neurons. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, targets the JNK pathway, affecting stress responses. By inhibiting JNK signaling, SP600125 might indirectly suppress Vmn1r209 expression, assuming the gene is regulated by stress or inflammatory signals. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, impacts cellular signaling pathways including those in sensory or neuronal cells. This could lead to indirect suppression of Vmn1r209 if its expression is regulated by tyrosine kinase-dependent pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin, known for its anti-inflammatory properties, modulates various signaling pathways. This modulation could affect Vmn1r209 expression, especially if the gene is responsive to inflammatory or stress-related signals. | ||||||